Meloxicam

Overview

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat pain and inflammation in rheumatic diseases and osteoarthritis. It works by inhibiting the synthesis of prostaglandins, which play a key role in inflammation.

API suppliers (20)

Suppliers of Meloxicam evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Cipla USA, Inc.USA1 active DMF
• ANONIMA MATERIE SINTETICHE AND AFFINI (AMSA) SPA1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF GMP on record
• SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF GMP on record
• Ipca Laboratories LimitedIndia1 active DMF GMP on record
• Apex Healthcare LimitedIndia1 active DMF
• BIDACHEM SPAItaly1 active DMF GMP on record
• ARCH PHARMALABS LTDIndia1 active DMF
• Unichem Laboratories Ltd.India1 active DMF GMP on record
• UNIMARK REMEDIES LTDIndia1 active DMF
• SWATI SPENTOSE PRIVATE LTDIndia1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• QUIMICA SINTETICA SASpain1 active DMF GMP on record
• DERIVADOS QUIMICOS SAUSpain1 active DMF
• UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain
• SICHUAN SANCHINE SUNNYHOPE PHARMACEUTICAL CO LTD
• DR REDDYS LABORATORIES LTD GMP on record
• ESTEVE QUIMICA SA GMP on record
• Micro Labs Ltd India
• Cadila Pharmaceuticals LimitedIndia GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (31 approved US products), the latest listed US patent on Meloxicam expires 31 Jul 2041. Generic API sourcing typically opens up once these lapse.

Therapeutic areas